Literature DB >> 12708947

Zolpidem-induced distortion in visual perception.

Chiung-Lei Huang1, Ching-Jui Chang, Chi-Feng Hung, Hsi-Yen Lin.   

Abstract

OBJECTIVE: To describe a patient who developed visual perception distortion after a single dose of zolpidem. CASE
SUMMARY: A 50-year-old Asian woman had been prescribed conjugated estrogen 1 tablet daily for hormone replacement therapy and tricalcium phosphate twice daily for osteoporosis. One day, she took zolpidem 10 mg for insomnia as well as acetaminophen 500 mg for headache at bedtime and began to have visual perception distortion (e.g., the shapes of objects were twisted, houses were crooked) within 20 minutes, lasting for approximately 30 minutes, and then her vision returned to normal. She only partially recalled the event. She had never taken zolpidem before, and she had not had any such disturbances in the past. DISCUSSION: There have been 21 case reports of zolpidem-related psychotic symptoms in the literature; however, the exact mechanism by which zolpidem may cause visual perception changes is undetermined. Many factors have been correlated with zolpidem-induced visual experiences, such as pharmacokinetic factors, gender, age, and hypoalbuminemia. This patient shared certain similarities such as gender, dosage, and time of onset and duration of adverse reactions.
CONCLUSIONS: An objective causality assessment revealed that the zolpidem-induced visual perception distortion in this patient was probable. Clinicians should be aware of the potential for visual perception distortion, as this is an uncommon adverse effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12708947     DOI: 10.1345/aph.1C318

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  7 in total

1.  Adverse reactions to zolpidem: case reports and a review of the literature.

Authors:  Takuji Inagaki; Tsuyoshi Miyaoka; Seiichi Tsuji; Yasushi Inami; Akira Nishida; Jun Horiguchi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation.

Authors:  Stephanie C Licata; Steven B Lowen; George H Trksak; Robert R Maclean; Scott E Lukas
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-30       Impact factor: 5.067

3.  Two cases of zolpidem-associated homicide.

Authors:  Cheryl M Paradis; Lawrence A Siegel; Stuart B Kleinman
Journal:  Prim Care Companion CNS Disord       Date:  2012-08-23

4.  A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T.

Authors:  Stephanie C Licata; J Eric Jensen; David M Penetar; Andrew P Prescot; Scott E Lukas; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2009-01-06       Impact factor: 4.530

5.  Overdose and Alcohol Sensitive Immediate Release System (OASIS) for Deterring Accidental Overdose or Abuse of Drugs.

Authors:  Manali Patki; Siddhant Palekar; Pavan Kumar Nukala; Richa Vartak; Ketankumar Patel
Journal:  AAPS PharmSciTech       Date:  2020-11-25       Impact factor: 3.246

6.  Zolpidem-induced suicide attempt: a case report.

Authors:  Sameh Mortaz Hejri; Mehrdad Faizi; Mohammad Babaeian
Journal:  Daru       Date:  2013-12-20       Impact factor: 3.117

7.  Multimodal Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated with the Use of Zolpidem.

Authors:  Dushad Ram; Najla Eiman; Basavana Gowdappa
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-08-31       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.